MYD88 and seminoma: Specifically, seminoma samples showed strong immunoreactivity for TP53, CD8A, STAT1, PTPRC, CCL5, and MYD88, while teratoma tissues exhibited heightened expression of HSP90AA1, TOP2A, HSP4A, CDK1, CCNB1, and TRIM28.